An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.

CONCLUSION: Treatment with NB, in addition to a reduced-calorie diet and increased physical activity, seems an effective and well-tolerated option for improving pathological eating behavior and losing weight in obese-BED patients.
LEVEL OF EVIDENCE: Level III case-control study.
PMID: 32356145 [PubMed - as supplied by publisher]

Source: Eating and weight disorders : EWD - April 29, 2020 Category: Eating Disorders & Weight Management Authors: Carbone EA, Caroleo M, Rania M, Calabrò G, Staltari FA, de Filippis R, Aloi M, Condoleo F, Arturi F, Segura-Garcia C Tags: Eat Weight Disord Source Type: research